查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2108382

甲基化晶片市場分析及預測（至2035年）：依類型、產品、服務、技術、組件、應用、製程及最終用戶分類

Methylation Chip Market Analysis and Forecast to 2035: Type, Product, Services, Technology, Component, Application, Process, End User
出版日期: | 出版商: Global Insight Services | 英文 350 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

全球甲基化晶片市場預計將從2025年的35億美元成長到2035年的60億美元，CAGR為5.5%。此市場結構較為一體化，其中科學研究應用約佔60%的市場佔有率，臨床診斷佔30%，其他應用佔10%。主要產品類型包括全基因組甲基化晶片和對稱甲基化晶片。受表觀遺傳學研究和個人化醫療需求成長的推動，甲基化晶片的部署數量穩步增加，尤其是在科研機構和臨床檢查室。

依應用領域分類，甲基化晶片市場可細分為癌症研究、表觀遺傳學、藥物研發、診斷、農業生物技術及其他領域。其中，到2025年，癌症研究領域將佔據最大的市場佔有率。此領域主導地位的取得主要歸功於DNA甲基化分析在闡明腫瘤發展機制、識別生物標記以及支持精準腫瘤學研究方面的日益廣泛的應用。甲基化晶片使研究人員能夠有效地分析全基因組的甲基化模式，輔助癌症分類、早期檢測和治療反應預測。全球癌症發生率的上升、癌症基因組學投資的增加以及製藥和生物技術公司對錶觀遺傳學技術的日益普及，都進一步推動了癌症研究應用中對基於甲基化晶片的解決方案的需求。

市場區隔
類型 DNA甲基化、RNA甲基化、蛋白質甲基化、其他
產品 甲基化晶片、試劑/試劑盒、軟體工具、其他
服務 甲基化分析服務、諮詢服務、客製化服務、其他
技術 微陣列技術、次世代定序（NGS）、質譜分析、其他
組件 晶片、試劑、緩衝液、其他
用途 癌症研究、表觀遺傳學、藥物開發、診斷、農業生物技術、其他
過程 樣品製備、資料分析、品管、其他
最終用戶 製藥公司、生技公司、學術研究機構、臨床試驗實驗室、其他

從技術角度來看，甲基化晶片市場可細分為微陣列技術、新一代定序（NGS）、質譜分析和其他技術。其中，新一代定序（NGS）技術預計將在預測期內實現最快成長。這一快速成長主要得益於市場對高性能、全面甲基化分析能力的日益成長的需求。 NGS 甲基化分析能夠提供更深入的基因組資訊、更高的準確性，並能夠分析大規模資料集中的複雜表觀遺傳修飾。精準醫療的日益普及、定序平台的進步、定序成本的降低以及癌症基因組學和表觀遺傳學領域研究活動的不斷拓展，預計將加速 NGS 技術在甲基化晶片市場的應用。

區域概覽

北美在基因組學研究、精準醫療和分子診斷領域處於主導地位，到2025年佔據甲基化晶片市場最大的佔有率。該地區受益於對癌症基因組學的巨額投資、先進的研究設施以及大規模生物標記發現計畫。製藥公司、學術機構和診斷檢測實驗室正擴大利用甲基化晶片進行疾病研究、藥物研發和個人化治療策略。政府對基因組學研究的大力資助、先進測序技術的廣泛應用以及分子診斷領域的持續創新，進一步鞏固了北美在全球甲基化晶片市場的主導地位。

預計亞太地區將在預測期內實現最快成長，這主要得益於基因組研究舉措的擴展、醫療保健領域投資的增加以及精準醫療技術的日益普及。中國、日本、韓國和印度等國家大力投資國家基因組計畫、癌症研究和分子診斷基礎設施。人們對個人化醫療的認知不斷提高、研究機構與生技公司之間合作的加強以及檢查室能力的提升，加速該地區的需求成長。技術的持續進步和政府對生命科學研究的日益支持，預計將推動亞太地區市場強勁成長。

主要趨勢和促進因素

在精準醫療和癌症研究領域不斷拓展應用。

精準醫療和分子診斷技術的日益普及是甲基化晶片市場的主要驅動力。 DNA甲基化譜分析已成為識別與癌症、神經系統疾病和其他複雜疾病相關的表觀遺傳生物標記的關鍵工具。研究機構、製藥公司和臨床實驗室擴大使用甲基化晶片進行疾病診斷、患者分層和生物標記發現。基因組研究和個人化醫療投入的不斷增加進一步刺激了市場需求。表觀遺傳學在治療研發和疾病預測中日益重要的角色也持續推動全球市場的成長。

高效能表觀遺傳分析技術的進步

甲基化晶片市場的一大趨勢是高性能平台的開發，這些平台能夠同時分析數十萬個甲基化位點。製造商們不斷推出晶片，這些晶片能夠擴大基因組覆蓋範圍、提高靈敏度並增強分析準確性，支持大規模研究。與新一代定序技術、雲端運算和自動化生物資訊學工作流程的整合，簡化複雜表觀遺傳資料的分析。這些創新使研究人員能夠更快、更全面地深入了解疾病機制，同時提高精準醫療和轉化研究應用的效率。

目錄

第1章 執行摘要

第2章 市場亮點

第3章 市場動態

  • 宏觀經濟分析
  • 市場趨勢
  • 市場促進因素
  • 市場機會
  • 市場限制因素
  • 年複合成長率分析
  • 影響分析
  • 新興市場
  • 技術藍圖
  • 戰略框架

第4章 細分市場分析

  • 市場規模及預測：依類型
    • DNA甲基化
    • RNA甲基化
    • 蛋白質甲基化
    • 其他
  • 市場規模及預測：依產品分類
    • 甲基化陣列
    • 試劑和試劑盒
    • 軟體工具
    • 其他
  • 市場規模及預測：依服務分類
    • 甲基化分析服務
    • 諮詢服務
    • 客戶服務
    • 其他
  • 市場規模及預測：依技術分類
    • 微陣列技術
    • 下一代定序（NGS）
    • 質譜分析
    • 其他
  • 市場規模及預測：依組件分類
    • 晶片
    • 試劑
    • 緩衝液
    • 其他
  • 市場規模及預測：依應用領域分類
    • 癌症研究
    • 表觀遺傳學
    • 藥物研發
    • 診斷
    • 農業生物技術
    • 其他
  • 市場規模及預測：依最終用戶分類
    • 製藥公司
    • 生技公司
    • 學術研究機構
    • 臨床實驗室
    • 其他
  • 市場規模及預測：依過程分類
    • 樣品製備
    • 資料分析
    • 品管
    • 其他

第5章 區域分析

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 其他拉丁美洲國家
  • 亞太地區
    • 中國
    • 印度
    • 韓國
    • 日本
    • 澳洲
    • 台灣
    • 其他亞太國家
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 西班牙
    • 義大利
    • 其他歐洲國家
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非
    • 撒哈拉以南非洲
    • 其他中東和非洲國家

第6章 市場策略

  • 供需差距分析
  • 貿易和物流限制
  • 定價和成本利潤率趨勢
  • 市場滲透率
  • 消費者分析
  • 監管概述

第7章 競爭訊息

  • 市場定位
  • 市場占有率
  • 競爭基準
  • 主要公司的策略

第8章 公司簡介

  • Illumina
  • Thermo Fisher Scientific
  • Agilent Technologies
  • Roche
  • Bio-Rad Laboratories
  • Qiagen
  • PerkinElmer
  • Zymo Research
  • Pacific Biosciences
  • Oxford Nanopore Technologies
  • Becton Dickinson
  • Merck KGaA
  • Danaher Corporation
  • Fluidigm
  • Promega Corporation
  • Takara Bio
  • New England Biolabs
  • Diagenode
  • Epigenomics AG
  • Active Motif

第9章 關於我們

簡介目錄
Product Code: GIS34653

The global Methylation Chip Market is projected to grow from $3.5 billion in 2025 to $6.0 billion by 2035, at a compound annual growth rate (CAGR) of 5.5%. The Methylation Chip Market is characterized by a moderately consolidated structure, with the top segments being research applications, accounting for approximately 60% of the market share, followed by clinical diagnostics at 30%, and others at 10%. Key product categories include whole-genome methylation chips and targeted methylation chips. The market sees a steady volume of installations, particularly in research institutions and clinical laboratories, driven by the increasing demand for epigenetic research and personalized medicine.

Based on Application, the Methylation Chip Market is divided into Cancer Research, Epigenetics, Drug Development, Diagnostics, Agricultural Biotechnology, and Others. Among these, the Cancer Research segment accounted for the largest market share in 2025. The leading position of this segment is attributed to the increasing use of DNA methylation analysis for understanding tumor development, identifying biomarkers, and supporting precision oncology research. Methylation chips enable researchers to analyze genome-wide methylation patterns efficiently, helping in cancer classification, early detection, and treatment response prediction. The growing prevalence of cancer worldwide, rising investments in cancer genomics, and increased adoption of epigenetic technologies by pharmaceutical and biotechnology companies are further driving demand for methylation chip-based solutions in cancer research applications.

Market Segmentation
TypeDNA Methylation, RNA Methylation, Protein Methylation, Others
ProductMethylation Arrays, Reagents and Kits, Software Tools, Others
ServicesMethylation Analysis Services, Consulting Services, Custom Services, Others
TechnologyMicroarray Technology, Next-Generation Sequencing (NGS), Mass Spectrometry, Others
ComponentChips, Reagents, Buffers, Others
ApplicationCancer Research, Epigenetics, Drug Development, Diagnostics, Agricultural Biotechnology, Others
ProcessSample Preparation, Data Analysis, Quality Control, Others
End UserPharmaceutical Companies, Biotechnology Companies, Academic and Research Institutes, Clinical Laboratories, Others

Based on Technology, the Methylation Chip Market is divided into Microarray Technology, Next-Generation Sequencing (NGS), Mass Spectrometry, and Others. Among these, the Next-Generation Sequencing (NGS) segment is projected to witness the fastest growth during the forecast period. The rapid growth of this segment is driven by the increasing demand for high-throughput and comprehensive methylation profiling capabilities. NGS-based methylation analysis provides deeper genomic insights, improved accuracy, and the ability to analyze complex epigenetic modifications across large datasets. The growing adoption of precision medicine, advancements in sequencing platforms, declining sequencing costs, and expanding research activities in cancer genomics and epigenetics are expected to accelerate the adoption of NGS technologies within the methylation chip market.

Geographical Overview

North America held the largest share of the Methylation Chip Market in 2025 due to its leadership in genomic research, precision medicine, and molecular diagnostics. The region benefits from substantial investments in cancer genomics, advanced research laboratories, and large-scale biomarker discovery programs. Pharmaceutical companies, academic institutions, and diagnostic laboratories increasingly utilize methylation chips for disease research, drug development, and personalized treatment strategies. Strong government funding for genomics research, widespread availability of advanced sequencing technologies, and continuous innovation in molecular diagnostics continue to strengthen North America's dominant position in the global methylation chip market.

Asia-Pacific is projected to experience the fastest growth throughout the forecast period owing to expanding genomic research initiatives, rising healthcare investments, and increasing adoption of precision medicine technologies. Countries such as China, Japan, South Korea, and India are investing heavily in national genomics programs, cancer research, and molecular diagnostic infrastructure. Growing awareness of personalized healthcare, increasing collaborations between research institutions and biotechnology companies, and improving laboratory capabilities are accelerating regional demand. Continuous technological advancements and expanding government support for life science research are expected to drive strong market growth across Asia-Pacific.

Key Trends and Drivers

Expanding Applications in Precision Medicine and Cancer Research:

The growing adoption of precision medicine and molecular diagnostics is a key driver for the Methylation Chip Market. DNA methylation profiling has become an essential tool for identifying epigenetic biomarkers associated with cancer, neurological disorders, and other complex diseases. Research institutions, pharmaceutical companies, and clinical laboratories are increasingly utilizing methylation chips for disease diagnosis, patient stratification, and biomarker discovery. Rising investments in genomic research and personalized healthcare are further stimulating demand. The expanding role of epigenetics in therapeutic development and disease prediction continues to strengthen market growth worldwide.

Advancements in High-Throughput Epigenetic Analysis Technologies:

A prominent trend in the Methylation Chip Market is the development of high-throughput platforms capable of analyzing hundreds of thousands of methylation sites simultaneously. Manufacturers are introducing chips with greater genomic coverage, improved sensitivity, and enhanced analytical accuracy to support large-scale research studies. Integration with next-generation sequencing technologies, cloud computing, and automated bioinformatics workflows is simplifying complex epigenetic data analysis. These innovations are enabling researchers to generate faster, more comprehensive insights into disease mechanisms while improving the efficiency of precision medicine and translational research applications.

Research Scope

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1 Executive Summary

  • 1.1 Market Size and Forecast
  • 1.2 Market Overview
  • 1.3 Market Snapshot
  • 1.4 Regional Snapshot
  • 1.5 Strategic Recommendations
  • 1.6 Analyst Notes

2 Market Highlights

  • 2.1 Key Market Highlights by Type
  • 2.2 Key Market Highlights by Product
  • 2.3 Key Market Highlights by Services
  • 2.4 Key Market Highlights by Technology
  • 2.5 Key Market Highlights by Component
  • 2.6 Key Market Highlights by Application
  • 2.7 Key Market Highlights by End User
  • 2.8 Key Market Highlights by Process

3 Market Dynamics

  • 3.1 Macroeconomic Analysis
  • 3.2 Market Trends
  • 3.3 Market Drivers
  • 3.4 Market Opportunities
  • 3.5 Market Restraints
  • 3.6 CAGR Growth Analysis
  • 3.7 Impact Analysis
  • 3.8 Emerging Markets
  • 3.9 Technology Roadmap
  • 3.10 Strategic Frameworks
    • 3.10.1 PORTER's 5 Forces Model
    • 3.10.2 ANSOFF Matrix
    • 3.10.3 4P's Model
    • 3.10.4 PESTEL Analysis

4 Segment Analysis

  • 4.1 Market Size & Forecast by Type (2020-2035)
    • 4.1.1 DNA Methylation
    • 4.1.2 RNA Methylation
    • 4.1.3 Protein Methylation
    • 4.1.4 Others
  • 4.2 Market Size & Forecast by Product (2020-2035)
    • 4.2.1 Methylation Arrays
    • 4.2.2 Reagents and Kits
    • 4.2.3 Software Tools
    • 4.2.4 Others
  • 4.3 Market Size & Forecast by Services (2020-2035)
    • 4.3.1 Methylation Analysis Services
    • 4.3.2 Consulting Services
    • 4.3.3 Custom Services
    • 4.3.4 Others
  • 4.4 Market Size & Forecast by Technology (2020-2035)
    • 4.4.1 Microarray Technology
    • 4.4.2 Next-Generation Sequencing (NGS)
    • 4.4.3 Mass Spectrometry
    • 4.4.4 Others
  • 4.5 Market Size & Forecast by Component (2020-2035)
    • 4.5.1 Chips
    • 4.5.2 Reagents
    • 4.5.3 Buffers
    • 4.5.4 Others
  • 4.6 Market Size & Forecast by Application (2020-2035)
    • 4.6.1 Cancer Research
    • 4.6.2 Epigenetics
    • 4.6.3 Drug Development
    • 4.6.4 Diagnostics
    • 4.6.5 Agricultural Biotechnology
    • 4.6.6 Others
  • 4.7 Market Size & Forecast by End User (2020-2035)
    • 4.7.1 Pharmaceutical Companies
    • 4.7.2 Biotechnology Companies
    • 4.7.3 Academic and Research Institutes
    • 4.7.4 Clinical Laboratories
    • 4.7.5 Others
  • 4.8 Market Size & Forecast by Process (2020-2035)
    • 4.8.1 Sample Preparation
    • 4.8.2 Data Analysis
    • 4.8.3 Quality Control
    • 4.8.4 Others

5 Regional Analysis

  • 5.1 Global Market Overview
  • 5.2 North America Market Size (2020-2035)
    • 5.2.1 United States
      • 5.2.1.1 Type
      • 5.2.1.2 Product
      • 5.2.1.3 Services
      • 5.2.1.4 Technology
      • 5.2.1.5 Component
      • 5.2.1.6 Application
      • 5.2.1.7 End User
      • 5.2.1.8 Process
    • 5.2.2 Canada
      • 5.2.2.1 Type
      • 5.2.2.2 Product
      • 5.2.2.3 Services
      • 5.2.2.4 Technology
      • 5.2.2.5 Component
      • 5.2.2.6 Application
      • 5.2.2.7 End User
      • 5.2.2.8 Process
    • 5.2.3 Mexico
      • 5.2.3.1 Type
      • 5.2.3.2 Product
      • 5.2.3.3 Services
      • 5.2.3.4 Technology
      • 5.2.3.5 Component
      • 5.2.3.6 Application
      • 5.2.3.7 End User
      • 5.2.3.8 Process
  • 5.3 Latin America Market Size (2020-2035)
    • 5.3.1 Brazil
      • 5.3.1.1 Type
      • 5.3.1.2 Product
      • 5.3.1.3 Services
      • 5.3.1.4 Technology
      • 5.3.1.5 Component
      • 5.3.1.6 Application
      • 5.3.1.7 End User
      • 5.3.1.8 Process
    • 5.3.2 Argentina
      • 5.3.2.1 Type
      • 5.3.2.2 Product
      • 5.3.2.3 Services
      • 5.3.2.4 Technology
      • 5.3.2.5 Component
      • 5.3.2.6 Application
      • 5.3.2.7 End User
      • 5.3.2.8 Process
    • 5.3.3 Rest of Latin America
      • 5.3.3.1 Type
      • 5.3.3.2 Product
      • 5.3.3.3 Services
      • 5.3.3.4 Technology
      • 5.3.3.5 Component
      • 5.3.3.6 Application
      • 5.3.3.7 End User
      • 5.3.3.8 Process
  • 5.4 Asia-Pacific Market Size (2020-2035)
    • 5.4.1 China
      • 5.4.1.1 Type
      • 5.4.1.2 Product
      • 5.4.1.3 Services
      • 5.4.1.4 Technology
      • 5.4.1.5 Component
      • 5.4.1.6 Application
      • 5.4.1.7 End User
      • 5.4.1.8 Process
    • 5.4.2 India
      • 5.4.2.1 Type
      • 5.4.2.2 Product
      • 5.4.2.3 Services
      • 5.4.2.4 Technology
      • 5.4.2.5 Component
      • 5.4.2.6 Application
      • 5.4.2.7 End User
      • 5.4.2.8 Process
    • 5.4.3 South Korea
      • 5.4.3.1 Type
      • 5.4.3.2 Product
      • 5.4.3.3 Services
      • 5.4.3.4 Technology
      • 5.4.3.5 Component
      • 5.4.3.6 Application
      • 5.4.3.7 End User
      • 5.4.3.8 Process
    • 5.4.4 Japan
      • 5.4.4.1 Type
      • 5.4.4.2 Product
      • 5.4.4.3 Services
      • 5.4.4.4 Technology
      • 5.4.4.5 Component
      • 5.4.4.6 Application
      • 5.4.4.7 End User
      • 5.4.4.8 Process
    • 5.4.5 Australia
      • 5.4.5.1 Type
      • 5.4.5.2 Product
      • 5.4.5.3 Services
      • 5.4.5.4 Technology
      • 5.4.5.5 Component
      • 5.4.5.6 Application
      • 5.4.5.7 End User
      • 5.4.5.8 Process
    • 5.4.6 Taiwan
      • 5.4.6.1 Type
      • 5.4.6.2 Product
      • 5.4.6.3 Services
      • 5.4.6.4 Technology
      • 5.4.6.5 Component
      • 5.4.6.6 Application
      • 5.4.6.7 End User
      • 5.4.6.8 Process
    • 5.4.7 Rest of APAC
      • 5.4.7.1 Type
      • 5.4.7.2 Product
      • 5.4.7.3 Services
      • 5.4.7.4 Technology
      • 5.4.7.5 Component
      • 5.4.7.6 Application
      • 5.4.7.7 End User
      • 5.4.7.8 Process
  • 5.5 Europe Market Size (2020-2035)
    • 5.5.1 Germany
      • 5.5.1.1 Type
      • 5.5.1.2 Product
      • 5.5.1.3 Services
      • 5.5.1.4 Technology
      • 5.5.1.5 Component
      • 5.5.1.6 Application
      • 5.5.1.7 End User
      • 5.5.1.8 Process
    • 5.5.2 France
      • 5.5.2.1 Type
      • 5.5.2.2 Product
      • 5.5.2.3 Services
      • 5.5.2.4 Technology
      • 5.5.2.5 Component
      • 5.5.2.6 Application
      • 5.5.2.7 End User
      • 5.5.2.8 Process
    • 5.5.3 United Kingdom
      • 5.5.3.1 Type
      • 5.5.3.2 Product
      • 5.5.3.3 Services
      • 5.5.3.4 Technology
      • 5.5.3.5 Component
      • 5.5.3.6 Application
      • 5.5.3.7 End User
      • 5.5.3.8 Process
    • 5.5.4 Spain
      • 5.5.4.1 Type
      • 5.5.4.2 Product
      • 5.5.4.3 Services
      • 5.5.4.4 Technology
      • 5.5.4.5 Component
      • 5.5.4.6 Application
      • 5.5.4.7 End User
      • 5.5.4.8 Process
    • 5.5.5 Italy
      • 5.5.5.1 Type
      • 5.5.5.2 Product
      • 5.5.5.3 Services
      • 5.5.5.4 Technology
      • 5.5.5.5 Component
      • 5.5.5.6 Application
      • 5.5.5.7 End User
      • 5.5.5.8 Process
    • 5.5.6 Rest of Europe
      • 5.5.6.1 Type
      • 5.5.6.2 Product
      • 5.5.6.3 Services
      • 5.5.6.4 Technology
      • 5.5.6.5 Component
      • 5.5.6.6 Application
      • 5.5.6.7 End User
      • 5.5.6.8 Process
  • 5.6 Middle East & Africa Market Size (2020-2035)
    • 5.6.1 Saudi Arabia
      • 5.6.1.1 Type
      • 5.6.1.2 Product
      • 5.6.1.3 Services
      • 5.6.1.4 Technology
      • 5.6.1.5 Component
      • 5.6.1.6 Application
      • 5.6.1.7 End User
      • 5.6.1.8 Process
    • 5.6.2 United Arab Emirates
      • 5.6.2.1 Type
      • 5.6.2.2 Product
      • 5.6.2.3 Services
      • 5.6.2.4 Technology
      • 5.6.2.5 Component
      • 5.6.2.6 Application
      • 5.6.2.7 End User
      • 5.6.2.8 Process
    • 5.6.3 South Africa
      • 5.6.3.1 Type
      • 5.6.3.2 Product
      • 5.6.3.3 Services
      • 5.6.3.4 Technology
      • 5.6.3.5 Component
      • 5.6.3.6 Application
      • 5.6.3.7 End User
      • 5.6.3.8 Process
    • 5.6.4 Sub-Saharan Africa
      • 5.6.4.1 Type
      • 5.6.4.2 Product
      • 5.6.4.3 Services
      • 5.6.4.4 Technology
      • 5.6.4.5 Component
      • 5.6.4.6 Application
      • 5.6.4.7 End User
      • 5.6.4.8 Process
    • 5.6.5 Rest of MEA
      • 5.6.5.1 Type
      • 5.6.5.2 Product
      • 5.6.5.3 Services
      • 5.6.5.4 Technology
      • 5.6.5.5 Component
      • 5.6.5.6 Application
      • 5.6.5.7 End User
      • 5.6.5.8 Process

6 Market Strategy

  • 6.1 Demand-Supply Gap Analysis
  • 6.2 Trade & Logistics Constraints
  • 6.3 Price-Cost-Margin Trends
  • 6.4 Market Penetration
  • 6.5 Consumer Analysis
  • 6.6 Regulatory Snapshot

7 Competitive Intelligence

  • 7.1 Market Positioning
  • 7.2 Market Share
  • 7.3 Competition Benchmarking
  • 7.4 Top Company Strategies

8 Company Profiles

  • 8.1 Illumina
    • 8.1.1 Overview
    • 8.1.2 Product Summary
    • 8.1.3 Financial Performance
    • 8.1.4 SWOT Analysis
  • 8.2 Thermo Fisher Scientific
    • 8.2.1 Overview
    • 8.2.2 Product Summary
    • 8.2.3 Financial Performance
    • 8.2.4 SWOT Analysis
  • 8.3 Agilent Technologies
    • 8.3.1 Overview
    • 8.3.2 Product Summary
    • 8.3.3 Financial Performance
    • 8.3.4 SWOT Analysis
  • 8.4 Roche
    • 8.4.1 Overview
    • 8.4.2 Product Summary
    • 8.4.3 Financial Performance
    • 8.4.4 SWOT Analysis
  • 8.5 Bio-Rad Laboratories
    • 8.5.1 Overview
    • 8.5.2 Product Summary
    • 8.5.3 Financial Performance
    • 8.5.4 SWOT Analysis
  • 8.6 Qiagen
    • 8.6.1 Overview
    • 8.6.2 Product Summary
    • 8.6.3 Financial Performance
    • 8.6.4 SWOT Analysis
  • 8.7 PerkinElmer
    • 8.7.1 Overview
    • 8.7.2 Product Summary
    • 8.7.3 Financial Performance
    • 8.7.4 SWOT Analysis
  • 8.8 Zymo Research
    • 8.8.1 Overview
    • 8.8.2 Product Summary
    • 8.8.3 Financial Performance
    • 8.8.4 SWOT Analysis
  • 8.9 Pacific Biosciences
    • 8.9.1 Overview
    • 8.9.2 Product Summary
    • 8.9.3 Financial Performance
    • 8.9.4 SWOT Analysis
  • 8.10 Oxford Nanopore Technologies
    • 8.10.1 Overview
    • 8.10.2 Product Summary
    • 8.10.3 Financial Performance
    • 8.10.4 SWOT Analysis
  • 8.11 Becton Dickinson
    • 8.11.1 Overview
    • 8.11.2 Product Summary
    • 8.11.3 Financial Performance
    • 8.11.4 SWOT Analysis
  • 8.12 Merck KGaA
    • 8.12.1 Overview
    • 8.12.2 Product Summary
    • 8.12.3 Financial Performance
    • 8.12.4 SWOT Analysis
  • 8.13 Danaher Corporation
    • 8.13.1 Overview
    • 8.13.2 Product Summary
    • 8.13.3 Financial Performance
    • 8.13.4 SWOT Analysis
  • 8.14 Fluidigm
    • 8.14.1 Overview
    • 8.14.2 Product Summary
    • 8.14.3 Financial Performance
    • 8.14.4 SWOT Analysis
  • 8.15 Promega Corporation
    • 8.15.1 Overview
    • 8.15.2 Product Summary
    • 8.15.3 Financial Performance
    • 8.15.4 SWOT Analysis
  • 8.16 Takara Bio
    • 8.16.1 Overview
    • 8.16.2 Product Summary
    • 8.16.3 Financial Performance
    • 8.16.4 SWOT Analysis
  • 8.17 New England Biolabs
    • 8.17.1 Overview
    • 8.17.2 Product Summary
    • 8.17.3 Financial Performance
    • 8.17.4 SWOT Analysis
  • 8.18 Diagenode
    • 8.18.1 Overview
    • 8.18.2 Product Summary
    • 8.18.3 Financial Performance
    • 8.18.4 SWOT Analysis
  • 8.19 Epigenomics AG
    • 8.19.1 Overview
    • 8.19.2 Product Summary
    • 8.19.3 Financial Performance
    • 8.19.4 SWOT Analysis
  • 8.20 Active Motif
    • 8.20.1 Overview
    • 8.20.2 Product Summary
    • 8.20.3 Financial Performance
    • 8.20.4 SWOT Analysis

9 About Us

  • 9.1 About Us
  • 9.2 Research Methodology
  • 9.3 Research Workflow
  • 9.4 Consulting Services
  • 9.5 Our Clients
  • 9.6 Client Testimonials
  • 9.7 Contact Us